Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

This publication has 31 references indexed in Scilit:

• Treatment of metastatic esophagus and gastric cancer.
  Seminars in Oncology, 2004
• Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
  Journal of Clinical Oncology, 2004
• Systemic treatment of gastric cancer
  European Journal of Gastroenterology & Hepatology, 2004
• Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
  British Journal of Cancer, 2003
• Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
  2002
• Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma
  Annals of Oncology, 2000
• Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
  British Journal of Cancer, 1995
• Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group
  British Journal of Cancer, 1994
• Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
  Cancer, 1993
• [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
  1987